Scientists decode Neuroblastoma's genetic secrets to personalize treatment
NCT ID NCT00588068
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 24 times
Summary
This study aims to understand the genetic and biochemical makeup of neuroblastic tumors, which can affect how aggressive the cancer is and what treatments work best. Researchers will analyze tumor samples, blood, bone marrow, and stem cells from over 2000 participants. The goal is to link these biological markers with patient outcomes to improve future therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-••••
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.